Product Information

NATEGLINIDE 60 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.1812 per EA under NDC 16571075809. Its NADAC has been published 234 times since Jun 1, 2022.

FDA first approved this application on Jun 18, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

NATEGLINIDE 60 MG TABLET

NATEGLINIDE
$0.1812per EA

Strength

60 mg/1

NDC

16571075809

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

NATEGLINIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA205544

FDA Approved

6/18/2018

TE Code

AB

On Market Since

12/16/2020

Pharmacological Classes

Glinide
Potassium Channel Antagonists

Price Statistics

The NADAC for NATEGLINIDE 60 MG TABLET has been published 234 times since Jun 1, 2022, and over the history we have for it it has declined 36.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1812 per EA
All-time high$0.3073 (Dec 14, 2022)
All-time low$0.1645 (May 22, 2024)
52-week high$0.2008
52-week low$0.1726
Median price$0.2149
Average price$0.2195
Largest weekly change+29.6% (Aug 21, 2024)
Weeks tracked234
Tracking sinceJun 1, 2022

Price History

1W

-7.8%

1M

+1.0%

3M

-4.7%

6M

-9.8%

1Y

-7.0%

3Y

-18.5%

5Y

N/A

All

-36.7%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of NATEGLINIDE 60 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for NATEGLINIDE 60 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.1812 per EA (NDC 16571075809), effective Nov 18, 2026.

How has the price of NATEGLINIDE 60 MG TABLET changed over time?

Over the history we have for it, the NADAC for NATEGLINIDE 60 MG TABLET has declined 36.7%. It has been tracked across 234 weekly CMS publications since Jun 1, 2022.

What are the highest and lowest recorded NADAC prices for NATEGLINIDE 60 MG TABLET?

Since Jun 1, 2022, the NADAC for NATEGLINIDE 60 MG TABLET has ranged from a low of $0.1645 (May 22, 2024) to a high of $0.3073 (Dec 14, 2022), with a median of $0.2149 per EA.

Are there cheaper alternatives to NATEGLINIDE 60 MG TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as NATEGLINIDE 60 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures NATEGLINIDE 60 MG TABLET?

NATEGLINIDE 60 MG TABLET (NDC 16571075809) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.